|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
7
|
|
pubmed:dateCreated |
2009-2-13
|
|
pubmed:databankReference |
|
|
pubmed:abstractText |
Ovarian suppression plus tamoxifen is a standard adjuvant treatment in premenopausal women with endocrine-responsive breast cancer. Aromatase inhibitors are superior to tamoxifen in postmenopausal patients, and preclinical data suggest that zoledronic acid has antitumor properties.
|
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/19213681,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19213681-19474438,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19213681-19484813,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19213681-19484814,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19213681-19484815,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19213681-19484816,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19213681-19484817,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19213681-19484818,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19213681-19508828,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19213681-19671024,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19213681-19751105,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19213681-20425611
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, Hormonal,
http://linkedlifedata.com/resource/pubmed/chemical/Aromatase Inhibitors,
http://linkedlifedata.com/resource/pubmed/chemical/Bone Density Conservation Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Diphosphonates,
http://linkedlifedata.com/resource/pubmed/chemical/Estrogen Antagonists,
http://linkedlifedata.com/resource/pubmed/chemical/Goserelin,
http://linkedlifedata.com/resource/pubmed/chemical/Imidazoles,
http://linkedlifedata.com/resource/pubmed/chemical/Nitriles,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Estrogen,
http://linkedlifedata.com/resource/pubmed/chemical/Tamoxifen,
http://linkedlifedata.com/resource/pubmed/chemical/Triazoles,
http://linkedlifedata.com/resource/pubmed/chemical/anastrozole,
http://linkedlifedata.com/resource/pubmed/chemical/zoledronic acid
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
1533-4406
|
|
pubmed:author |
pubmed-author:ABCSG-12 Trial Investigators,
pubmed-author:Bjelic-RadisicVesnaV,
pubmed-author:DubskyPeterP,
pubmed-author:EidtmannHolgerH,
pubmed-author:FitzalFlorianF,
pubmed-author:FridrikMichaelM,
pubmed-author:GnantMichaelM,
pubmed-author:GreilRichardR,
pubmed-author:HubalekMichaelM,
pubmed-author:JakeszRaimundR,
pubmed-author:KwasnyWernerW,
pubmed-author:Luschin-EbengreuthGeroG,
pubmed-author:MartiBB,
pubmed-author:MenzelChristianC,
pubmed-author:MlineritschBrigitteB,
pubmed-author:PöstlbergerSabineS,
pubmed-author:RücklingerErnstE,
pubmed-author:SamoniggHellmutH,
pubmed-author:SchippingerWalterW,
pubmed-author:SeifertMichaelM,
pubmed-author:StegerGüntherG,
pubmed-author:StiererMichaelM,
pubmed-author:TauschChristophC
|
|
pubmed:copyrightInfo |
2009 Massachusetts Medical Society
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
12
|
|
pubmed:volume |
360
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
679-91
|
|
pubmed:dateRevised |
2010-11-5
|
|
pubmed:meshHeading |
pubmed-meshheading:19213681-Adult,
pubmed-meshheading:19213681-Antineoplastic Agents, Hormonal,
pubmed-meshheading:19213681-Aromatase Inhibitors,
pubmed-meshheading:19213681-Bone Density Conservation Agents,
pubmed-meshheading:19213681-Breast Neoplasms,
pubmed-meshheading:19213681-Chemotherapy, Adjuvant,
pubmed-meshheading:19213681-Diphosphonates,
pubmed-meshheading:19213681-Disease-Free Survival,
pubmed-meshheading:19213681-Drug Therapy, Combination,
pubmed-meshheading:19213681-Estrogen Antagonists,
pubmed-meshheading:19213681-Female,
pubmed-meshheading:19213681-Follow-Up Studies,
pubmed-meshheading:19213681-Goserelin,
pubmed-meshheading:19213681-Humans,
pubmed-meshheading:19213681-Imidazoles,
pubmed-meshheading:19213681-Middle Aged,
pubmed-meshheading:19213681-Nitriles,
pubmed-meshheading:19213681-Premenopause,
pubmed-meshheading:19213681-Receptors, Estrogen,
pubmed-meshheading:19213681-Tamoxifen,
pubmed-meshheading:19213681-Triazoles
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Endocrine therapy plus zoledronic acid in premenopausal breast cancer.
|
|
pubmed:affiliation |
Medical University of Vienna, Austria. michael.gnant@meduniwien.ac.at
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
